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Abstract The inability to propagate human norovirus
(NoV) or to clearly differentiate infectious from nonin-
fectious virus particles has led to the use of surrogate
viruses, like feline calicivirus (FCV) and murine norovirus-
1 (MNV), which are propagatable in cell culture. The use
of surrogates is predicated on the assumption that they
generally mimic the viruses they represent; however,
studies are proving this concept invalid. In direct com-
parisons between FCV and MNV, their susceptibility to
temperatures, environmental and food processing condi-
tions, and disinfectants are dramatically different. Differ-
ences have also been noted between the inactivation of
NoV and its surrogates, thus questioning the validity of
surrogates. Considerable research funding is provided
globally each year to conduct surrogate studies on NoVs;
however, there is little demonstrated beneﬁt derived from
these studies in regard to the development of virus inacti-
vation techniques or food processing strategies. Human
challenge studies are needed to determine which process-
ing techniques are effective in reducing NoVs in foods.
A major obstacle to clinical trials on NoVs is the percep-
tion that such trials are too costly and risky, but in reality,
there is far more cost and risk in allowing millions of
unsuspecting consumers to contract NoV illness each year,
when practical interventions are only a few volunteer
studies away. A number of clinical trials have been con-
ducted, providing important insights into NoV inactivation.
A shift in research priorities from surrogate research to
volunteer studies is essential if we are to identify realistic,
practical, and scientiﬁcally valid processing approaches to
improve food safety.
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Introduction
Human noroviruses (NoVs) are a primary cause of viral
gastroenteritis throughout the world (Siebenga et al. 2009),
and the principle cause of foodborne illness in Europe
(Kroneman et al. 2008; Phillips et al. 2010) and the United
States (Mead et al. 1999; Scallan et al. 2011). The number
of estimated cases in the United States was recently revised
to 5.5 million annually (Scallan et al. 2011), while England
has an estimated 2 million cases per year (Phillips et al.
2010). As enteric viruses, the NoVs are spread via the feces
or vomitus of infected individuals. Norovirus illness is
contracted through contaminated food and water and direct
person-to-person transmission. Contamination often arises
during the handling and preparation of foods, although
there are many instances where foods, particularly shell-
ﬁsh, are contaminated within their environment. Products
requiring extensive handling are also prone to contamina-
tion. In spite of interventions to eliminate product con-
tamination, like thorough cooking, some products, such as
salads and molluscan shellﬁsh are typically eaten raw or
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greatest risk to the consumer (Richards 2001; Richards
et al. 2010).
The development of commercial processing strategies
for foods has been largely based on reductions in bacterial
pathogens, and only to a lesser extent on the inactivation of
enteric viruses. For some of the enteric viruses, like
poliovirus and related Picornaviridae, astroviruses, parv-
oviruses, rotaviruses, and adenoviruses 40 and 41, the
levels of infectious virus particles can be determined using
cell or tissue culture, since these viruses are propagatable.
Unfortunately, NoV cannot be routinely propagated in cell
culture or animal models. Human exposure and resulting
illness are currently the only means to distinguish infec-
tious from inactivated NoVs. Scientists and regulators have
relied on virus detection in foods based on the physical
presence of viral RNA, as determined by reverse tran-
scription-PCR, which presently cannot distinguish between
infectious and inactivated viruses (Richards 1999),
although methods are being developed toward that goal (Li
et al. 2011; Nuanualsuwan and Cliver 2002; Parshionikar
et al. 2010). The lack of a suitable assay for infectious NoV
and other unculturable viruses, like most wild-type strains
of hepatitis A virus (HAV), has led the research community
to focus on viral surrogates. Surrogates are viruses related
to the pathogens they have been chosen to represent. The
selection of a surrogate, at least in regard to NoVs, has
been based on the ability of the surrogate to be propagated
in culture, and its genetic, physical, or chemical relatedness
to the pathogen. Over the years, different surrogates have
been selected for use in determining the uptake, persis-
tence, distribution, and inactivation of viruses in foods,
water, and environmental samples as well as in chemical
disinfection studies on surfaces. Studies with surrogates
have been used with the intent to develop a better under-
standing about the pathogens they represent as well as
applied applications for pathogen elimination.
A respiratory virus known as feline calicivirus (FCV) in
the genus Vesivirus was ﬁrst used as a NoV surrogate in the
late 1990s (Doultree et al. 1999; Slomka and Appleton
1998). It has been commonly employed in studies involv-
ing chemical disinfectants (Cannon et al. 2006; D’Souza
and Su 2010; Doultree et al. 1999; Gehrke et al. 2004;
Hudson et al. 2007; Jimemez and Chiang 2006; Kampf
et al. 2005; Lages et al. 2008; Malik et al. 2006; Malik and
Goyal 2006; Mori et al. 2007; Morino et al. 2009; Pos-
chetto et al. 2007; Sattar et al. 2011; Steinmann 2004;
Urakami et al. 2007; Whitehead and McCue 2010); and
processing interventions, like heating (Buckow et al. 2008;
Butot et al. 2009; Cannon et al. 2006), freezing or freeze-
drying (Butot et al. 2008, 2009), irradiation (de Roda
Husman et al. 2004; Fino and Kniel 2008; Nuanualsuwan
et al. 2002), marinating/acidiﬁcation (Cannon et al. 2006;
Hewitt and Greening 2004), and high pressure processing
(Chen et al. 2005; Kingsley et al. 2002). A decade after
FCV ﬁrst came on the scene, Wobus et al. (2006) identiﬁed
murine norovirus-1 (MNV) as a closer genetic relative of
NoV. Now, MNV has become the more commonly used
surrogate for chemical disinfection studies (Belliot et al.
2008; Cannon et al. 2006; D’Souza and Su 2010;
Lee et al. 2008; Lim et al. 2010; Magulski et al. 2009; Park
et al. 2010; Sattar et al. 2011); and studies on processing
interventions like heating (Baert et al. 2008a; Cannon et al.
2006; Hewitt et al. 2009; Sow et al. 2011; Tanner 2009),
freezing (Baert et al. 2008b), UV irradiation (Jean et al.
2011; Park et al. 2011), gamma irradiation (Feng et al.
2011), electron beam (Sanglay et al. 2011), and high
pressure processing (Kingsley et al. 2007; Lou et al. 2011;
Tang et al. 2010). Poliovirus and bacteriophage MS2 have
also been used as potential surrogates for NoV (Bae and
Schwab 2008; D’Souza and Su 2010; Dawson et al. 2005;
Shin and Sobsey 2003). Another potential surrogate is the
recently discovered rhesus monkey calicivirus, known as
Tulane virus, which can replicate in cell culture, but as
indicated by Tan and Jiang (2010), may not serve as a good
model for human NoV because it is not in the norovirus
genus and has not been shown to cause gastroenteritis like
the human NoVs. Unfortunately, there are fundamental
differences in the inactivation rates of many closely related
viruses—differences which may limit their role as
surrogates.
Limitations of Viral Surrogates
Surrogate viruses are generally expected to mimic the
viruses they represent, although studies are proving this
concept invalid. In direct comparisons between FCV and
MNV, their susceptibility to temperatures, pH, and envi-
ronmental conditions has been shown to be dramatically
different (Cannon et al. 2006). In these studies, MNV was
signiﬁcantly more resistant to both acidic and alkaline pHs
than FCV; MNV was more resistant than FCV to chloro-
form, Freon, and Vertrel; FCV was more stable than MNV
at 56C( P\0.05), but differences were not signiﬁcant at
63 and 72C; and MNV was more stable in solution at
room temperature (Cannon et al. 2006). Gibson and
Schwab (2011) reported that FCV was signiﬁcantly less
stable than MNV at 50C, but not signiﬁcantly different at
60C. In these same studies, HAV was signiﬁcantly more
resistant than FCV and MNV to heat treatment at 50 and
60C (Gibson and Schwab 2011). Bae and Schwab (2008)
evaluated the persistence of FCV, MNV, MS2 and polio-
virus in surface water and groundwater and found that
FCV was signiﬁcantly less stable than MNV, MS2, and
poliovirus. Sattar et al. (2011) compared the effects of
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showed that over a short contact time (20 s) that FCV was
100 times more resistant to inactivation than MNV. In
another study on hand sanitizers, FCV was more sensitive
to some low pH sanitizers than MNV; however, MNV was
more readily inactivated by alcohols, thus the recommen-
dation was made to include both surrogates when testing
hand sanitizers (Park et al. 2010). A study on the inacti-
vation of FCV and MNV by UV irradiation (254 nm)
showed FCV to be more sensitive than MNV (Park et al.
2011). D’Souza and Su (2010) evaluated the effects of
chemical treatments to inactivate FCV, MNV, and MS2
and reported that a 2% trisodium phosphate treatment for
1 min decreased FCV and MS2 by over 6 logs, but MNV
by only 1 log. They also showed that 2% glutaraldehyde
reduced FCV and MNV titers by 6 logs, but MS2 by \3
logs. Seventy percent ethanol was reported to cause no
reduction in titers for any of the viruses (D’Souza and Su
2010). Ueki et al. (2007) compared the persistence of NoV
and FCV in the digestive tissues of the oyster after depu-
ration for 10 days and concluded that FCV was rapidly
depleted, whereas NoV persisted. We now know that NoV
binds to histo-blood group antigens (HBGAs) present on
gastrointestinal cells of oysters, clams, and mussels (Le
Guyader et al. 2006; Tian et al. 2006, 2007), which may
account for differences in virus uptake by shellﬁsh. Tulane
virus also binds to HBGAs (Farkas et al. 2010), while
MNV and FCV bind to sialic acid on the host cell surface
(Stuart and Brown 2007; Taube et al. 2009). These results
should lead one to conclude that not all virus surrogates are
equal; some surrogates are more similar while others are
quite different from the pathogens they represent.
A major limitation in these studies is a lack of correla-
tion in the inactivation rates of the surrogates and of the
pathogen. Koopmans and Duzier (2004) suggested the use
of the most resistant enteric virus in developing food safety
guidelines. This may over regulate the industry if NoV is
substantially more susceptible than the surrogate. On the
other hand, even the most resilient surrogate may not be as
resistant as the pathogen, and may lead to a false sense of
security relative to the safety of food or water. Unfortu-
nately, there is often no information available to directly
correlate the pathogen with its ascribed surrogate, leaving
regulators unable to promulgate new food regulations
based on surrogate studies. In addition, a surrogate may be
representative of a pathogen’s response to a particular
processing scenario (e.g., pasteurization), but may not
necessarily represent a pathogen’s response under other
processing conditions or in other food matrices. Data
obtained must be carefully scrutinized and treated as pre-
sumptive evidence of how the pathogen may respond to a
particular treatment. The use of FCV as a surrogate has
diminished as more researchers are utilizing MNV, which
is genetically more similar to NoV than FCV. Conse-
quently, past FCV research is being looked on as unreli-
able, while MNV is rapidly gaining popularity as a more
suitable surrogate, in spite of the fact that FCV seems more
resistant to chemical disinfectants than MNV.
The question today is whether MNV is an adequate
surrogate for NoV—one that closely mimics the virus it
represents. Is MNV the answer? Probably not. The reason
is that MNV may fail to respond in the same manner as the
pathogen it represents. This was demonstrated in a volun-
teer study involving the inactivation of NoV in oysters
using high pressure processing (Leon et al. 2011). In this
study, pressures of up to 600 megaPascals (MPa) for 5 min
at room temperature were required to totally eliminate 4
logs of NoV (Leon et al. 2011). In comparison, only
250 MPa was required to inactivate 7 logs of FCV in cell
culture media under the same conditions, while 4 logs of
MNV required 400 MPa for 5 min at 5C for inactivation
(Kingsley et al. 2002, 2007; Leon et al. 2011). One of the
problems in comparing such studies is differences in pro-
cessing conditions or matrix between assays. Here, we see
different matrices (cell culture media and oysters) and
different processing conditions (room temperature and
5C); however, no other comparative studies exist for this
processing technology.
Another example of the differences in the inactivation
of related viruses may be seen for poliovirus and HAV.
Poliovirus has been used as a surrogate for HAV because of
its similarity in size, shape, and structure to HAV; how-
ever, high pressure processing can inactivate HAV at
pressures around 400 MPa, but poliovirus persists at
600 MPa (Kingsley et al. 2002; Wilkinson et al. 2001).
Another study showed that different strains of cell culture-
adapted HAV have different sensitivities to heat and high
pressure, where heating to 60C for 10 h and pressures of
420 MPa reduced virus infectivity by anywhere from 3 to 5
logs, depending on the strain (Shimasaki et al. 2009). This
represents a 100-fold difference in the inactivation of dif-
ferent strains of HAV and highlights how different strains
of the same virus do not accurately portray the inactivation
dynamics of all HAV strains. Much like the differences in
inactivation noted among HAV strains, different responses
to inactivation should be anticipated among the NoV
strains. Different strains of FCV also showed widely dif-
fering susceptibilities to inactivation by three alcohol
mixtures and a chlorine compound (Di Martino et al. 2010)
and to pH and heat (Lee and Gillespie 1973). If strains of
the same virus give discordant inactivation results, then one
might expect virus surrogates, which are only slightly
related to the pathogens, to be poor indicators of the
pathogen’s inactivation kinetics. NoVs include a variety of
genetically similar strains (also called genotypes or clus-
ters) within two genogroups (I and II). The uptake of
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cluster 1 NoV (Norwalk virus strain) efﬁciently biocon-
centrated, but genogroup II, cluster 4 NoV poorly bio-
concentrated (Maalouf et al. 2011). Consequently, the use
of a surrogate for viruses that differ widely in their genetic
composition and likely in their response to various pro-
cessing techniques, chemical disinfection, or environmen-
tal conditions seems counterproductive. Although the most
resistant surrogates may be used to evaluate processing
effectiveness, the pathogens could be several orders of
magnitude more resistant to treatment than the surrogate.
Predictive models have been proposed for NoV and HAV
inactivation in shellﬁsh, based on the use of surrogates,
either FCV or a cell culture-adapted strain of HAV (Buc-
kow et al. 2008; Grove et al. 2009); however, such models
are not likely to accurately portray the inactivation of
pathogenic viruses on or within foods. With the likelihood
that MNV will not accurately reﬂect the conditions nec-
essary to inactivate NoV in foods, one questions the
funding of surrogate studies. Will MNV become another
FCV, with millions of dollars spent on research but little
conﬁdence in the results?
Costs and Beneﬁts
Considerable research funding is provided globally each
year to conduct surrogate studies on NoV; however, there
is little beneﬁt derived from these studies in regard to the
development of food processing strategies. After years of
research with FCV as the surrogate, investigators are
considering those results highly presumptuous, particularly
in light of MNV which is now generally perceived as a
better surrogate. The time, effort, and cost that were
devoted to surrogate research with FCV may have been
misdirected. At what cost was the FCV research con-
ducted? No one can be sure, but certainly millions of
dollars have been spent on what is now considered by most
as an ineffectual surrogate. A similar fate will befall MNV
when researchers identify still better surrogates for NoV
and similar or greater dollar losses can be expected.
Uncertainty concerning the reliability of surrogate studies
has, to the best of this author’s knowledge, prevented
results from being implemented in regulatory actions or
new food processing procedures. If information were
available on how much money was spent on surrogate
studies and one were to conduct a cost–beneﬁt analysis on
the FCV or MNV studies performed to date, results would
be startling, since there has been much money spent, but
with little change in the way we process foods or sanitize
the workplace. At the time of this writing (September,
2011), a number of papers had already been published
during 2011 on the use of MNV as a NoV surrogate,
including the use of varying processing technologies, like
electron beam (Sanglay et al. 2011); gamma irradiation
(Feng et al. 2011), and high pressure processing (Lou et al.
2011) to inactivate MNV in produce; heat inactivation of
MNV in clams (Sow et al. 2011); chemical disinfectants to
eliminate MNV on produce and food contact surfaces
(Predmore and Li 2011) and hands (Park et al. 2011; Sattar
et al. 2011); and pulsed UV light inactivation of MNV on
food contact surfaces (Jean et al. 2011). Such studies fail to
provide reasonable expectations that the surrogates respond
in a similar manner to NoV or to different genogroups or
strains of NoV. In spite of the well intentioned and com-
petent research that has been performed on NoV surro-
gates, results derived from surrogate studies have not
answered the important questions regarding NoV inacti-
vation in foods, water, or on food contact surfaces. We
need to ask ourselves if FCV or MNV could ever be used in
establishing food processing regulations when they only
provide a glimmer of how the pathogen might respond to
certain conditions. With all this uncertainty about surro-
gates, how does one derive deﬁnitive answers concerning
what methods are needed to inactivate NoVs? The answer
is human clinical trials.
Need for Clinical Trials
Current practices to evaluate surrogate viruses and to
employ molecular assays should be limited, particularly for
NoV inactivation studies. It is hereby recommended that
presumptive information derived from the use of surrogates
be subjected to proof-of-principle testing and validated in
volunteer studies using NoV. Human challenge studies are
essential to determine which processing techniques are
effective in reducing NoV in foods. NoV is considered the
primary cause of gastrointestinal illness worldwide. With
such high morbidity rates, strategically designed volunteer
studies performed under controlled conditions would seem
prudent in order to assess the effects of cooking, freezing,
irradiation, disinfectants, and other processing technologies
on virus inactivation. The cost for challenge studies would
be high; however, the results would be deﬁnitive. A case in
point was the recent volunteer study to assess the effec-
tiveness of high pressure processing to inactivate NoV in
oysters, where it was deﬁnitively shown that pressure of
up to 600 MPa for 5 min at room temperature would be
required to inactivate 4 logs of the genogroup I.1 (Norwalk
virus) strain of NoV (Leon et al. 2011). Does this mean that
the same processing conditions would be required to
inactivate the same level of other NoV strains? No, not at
all, but is seems likely that differences between NoV
strains would be less than differences between NoVs and
their so called surrogates.
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a study performed in Australia where shellﬁsh containing
NoV were ‘‘puriﬁed’’ by depuration (Grohmann et al.
1981). Depurated oysters were subsequently fed to volun-
teers who became ill, thus demonstrating that commercial
depuration was not effective in eliminating NoV in con-
taminated oysters (Grohmann et al. 1981). In this case,
volunteer studies provided deﬁnitive answers about the
infectiousness of the shellﬁsh. Volunteer studies can pro-
vide a ﬁrm basis for developing food and water processing
strategies and for making regulatory decisions. Until such
time that researchers develop a cell culture propagation
system for NoV, or other means to discriminate infectious
from inactive NoV, human challenge studies are our best
hope for determining true virus inactivation parameters.
This recommendation to limit surrogate studies will be
highly controversial, since funding for surrogate research
has been plentiful and many researchers (including those
in my laboratory) are accustomed to conducting NoV
research with virus surrogates. However, a shift in research
directions is essential if we are to identify realistic and
practical processing strategies to improve food safety.
Former and present research conducted with NoV surro-
gates will likely contribute little to improving the world’s
food supply, while the costs of such studies could be
pooled and redirected to more deﬁnitive clinical trials on
NoV inactivation. Future surrogate studies should be con-
sidered only when the research is well justiﬁed with a clear
delineation of why a study with surrogates is appropriate
and what deﬁnitive information is anticipated. Surrogate
studies should be linked, to the extent possible, with NoV
volunteer studies to determine if the inactivation rates of
surrogates and NoVs correlate after various processing
interventions. Similar inactivation proﬁles would validate
the surrogate for a particular use under deﬁned conditions.
Clinical trials will again be necessary to validate some
of the new and upcoming assays that are designed to dif-
ferentiate infectious from inactivated viruses, such as pre-
treatment of viruses with proteinase K and ribonuclease
before RT-PCR (Nuanualsuwan and Cliver 2002), use of
ethidium and propidium monoazide in conjunction with
RT-PCR assays (Kim et al. 2011; Parshionikar et al. 2010),
and various receptor and binding assays, like one devel-
oped by Li et al. (2011) using MNV. Virus surrogates may
play a role in the development of assays for NoV infec-
tivity; however, conﬁrmation that the surrogates are truly
representative of NoV must be accomplished by volunteer
studies. For instance, receptor binding assays which show
that MNV only binds when it is infectious, should be linked
with volunteer studies designed to evaluate the assay using
NoV of demonstrated infectivity, as determined by clinical
trials. Many in vitro surrogate studies suggest that NoV can
be inactivated by one treatment or another, but fail to carry
the work forward to validate the results using similar
treatments of NoV in volunteer studies.
Over the years, a number of NoV volunteer studies have
been performed. My laboratory just completed a 5-year
collaborative study that involved clinical trials at Emory
University in Atlanta (Leon et al. 2011). Since 1994, there
were seven separate trials involving 190 volunteers at
Emory University and the University of North Carolina at
Chapel Hill (Lindesmith et al. 2003, 2005, 2010) and there
were no adverse reactions among any of the volunteers
(personal communication, Christine Moe, Emory Univer-
sity). Other clinical trials involving NoVs have been per-
formed at Baylor College of Medicine (Graham et al. 1994;
Hutson et al. 2002, 2005) and elsewhere (Wyatt et al. 1974;
Dolin et al. 1982). NoV illness is usually a temporary
imposition where adverse effects outside of the usual
nausea, diarrhea, and vomiting are seldom encountered;
therefore, there is reasonable expectation that trials may be
conducted with minimal risk of complications. Oversight
of clinical trials must be provided by institutional review
boards for human subjects or similar entities whose mission
is to evaluate potential patient risks, to ensure they are
minimized to the extent possible, and to weigh the risks
versus beneﬁts of the proposed research. Costs for studies
vary greatly, but an average volunteer may expect com-
pensation of approximately $1000 (US) for their partici-
pation and incarceration in the hospital for 3 or 4 days.
Hospital costs, labor, and overhead for researchers add to
the overall expense, thus the cost of a volunteer study may
approach $500,000 (US) in today’s market, depending on
the number of volunteers required to provide statistically
signiﬁcant results. If monies that were normally used for
surrogate studies were pooled, then multiple volunteer
studies could likely be funded each year.
One obstacle to clinical trials is the perception that such
trials are risky. The threat of lawsuits, in the event of
unforeseen circumstances, prevents some governments,
universities, and hospitals from conducting or considering
thefundingofsuchstudies.Inreality,thereisfarmoreriskin
allowing millions of unsuspecting consumers to contract
NoV each year, when practical interventions are only a few
volunteer studies away. The price to pay for inactivity is
great, with lost wages, medical costs, and regulatory and
epidemiological expenses involved in tracking and manag-
ing outbreaks. Costs of supporting clinical trials would be a
small price to pay for the considerable savings that would be
broughtaboutbyevenamodestreductioninNoVoutbreaks.
A change in attitudes and a shift in research priorities are
essential if we are to win the battle against NoV illness.
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